EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns Berlin (Germany), May 19, 2023 -The Member […]
Category: Press Releases
19. May 2023
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
Read more
28. April 2023
Epigenomics AG publishes financial results for fiscal year 2022
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2022 28.04.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2022 Berlin (Germany) and San Diego, CA (U.S.A.), April 28, 2023 – Epigenomics AG (FSE: ECX, […]
12. April 2023
Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Chief Executive Officer Greg Hamilton Resigns 12.04.2023 / 20:05 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns Berlin (Germany), April 12, 2023 – The Chief Executive Officer of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]
10. March 2023
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of CompanyEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with […]
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/Financing Epigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of […]
15. February 2023
Epigenomics decides to restructure to minimize costs
EQS-News: Epigenomics AG / Key word(s): Restructure of Company/FinancingEpigenomics decides to restructure to minimize costs 15.02.2023 / 11:18 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics decides to restructure to minimize costs Berlin (Germany) and San Diego, CA (U.S.A.) February 15, 2023 – The Executive Board of Epigenomics AG (Frankfurt Prime […]